opinion leader science and medical-marketing intelligence servicesBy focusing on drugs and medical devices we’ve been able to build the highest level of expertise in the industry. The greater the expertise, the better the analysis—and the more useful the intelligence..
With an objective, scientific approachWe apply a rigorous, evidence-based approach to gathering and analyzing data. By leveraging our proprietary data mining and semantic learning tools, we’re able to provide insights and strategic recommendations with a high degree of confidence.,
superior medical and business expertiseWe have more medical and scientific professionals on our team—MDs, PharmDs, and PhDs—than any other company in our field. Joining them are highly qualified marketing and technology experts. Greater expertise means better intelligence.,
and a deep understanding of our clients’
competitive landscapeOur team includes experienced industry professionals. We attend medical conferences and symposia, follow the industry closely, and have strong relationships with opinion leaders. With our exclusive focus on the pharmaceutical, biotechnology, and medical device industries, we truly understand our clients’ brands and the markets in which they compete., we offer not just
information but guidanceWe go beyond gathering and analyzing data. We’re able to guide you in the optimal application of your resources, helping you build and manage relationships with the right medical experts—giving your brand the support it requires..
In doing so, we help our clients
optimize the clinical and commercial potential of their brandsThose whose opinions matter most will directly affect the fate of your brand, both before and after launch. We help you identify those whose opinions really matter. We measure and track their sentiment, and help you build strong relationships with them so you can benefit from their expertise in guiding your clinical development plan, communication strategy, market-shaping initiative, and launch efforts..
the minimum effective dose of aspirin for prevention of stroke and heart attack. We chose it for our name because it symbolizes the most efficient investment of resources for the maximum return. is a pioneer in opinion leader science and medical-marketing intelligenceUsing our proprietary data mining and analytic tools, we gather information about those whose opinions matter most. We measure and track their sentiments. And we provide recommendations that optimize your budget and improve your brand’s chances for success..
Headquartered in New York City, we serve
global pharmaceutical, biotechnology, and medical device clients with brands at all stages of development.
Our teamThe 81qd team includes medical, scientific, marketing, and business technology professionals. (And they’re here, at our New York headquarters, not outsourced overseas.) is made up of scientific, medical, marketing, and business technology professionals. We bring more relevant expertise to bear on your business than any other company in our field.
We work every day at the critical junction of science and business. Contact us to learn how we can improve your brand’s chances for success.
- Leon Behar, PharmD
Chief Executive Officer
A founding partner of 81qd, Leon has dedicated his career to the application of data analytics to the design of strategic medical communications initiatives that drive brand market share. Leon has been instrumental in the launch of products across a wide range of therapeutic areas, including allergy and asthma, cardiology, endocrinology, immunology, infectious diseases, neurology, oncology, pain management, psychiatry, rheumatology, and women's health, and he has been recognized by the pharmaceutical industry for excellence in clinical communications. Leon earned his doctor of pharmacy degree at the Arnold and Marie Schwartz College of Pharmacy in Brooklyn, New York.
- Matthew H Weingarten, MD, MPH
Matthew has spent the last 10 years leading multidisciplinary teams responsible for conceptualizing, developing, and delivering industry-supported initiatives. His work in KOL science includes local, regional, national, and international KOL identification, profiling, sentiment analysis, network mapping, and engagement planning.
Matthew was trained in internal medicine at Lenox Hill Hospital in New York City where, as chief of primary care for a decade, he oversaw student, resident, and continuing medical education for the Department of Medicine. He later became chief medical officer for the first physician Internet company—an early example of the role of social media in medical opinion leadership.
Matthew received his medical degree from the School of Medicine and Biomedical Sciences at the State University of New York at Buffalo, and his master’s degree in public health from the Mailman School of Public Health of Columbia University.
We identify opinion leaders and other stakeholdersWhile clinicians are rightfully the focus of most efforts, there are other professionals whose opinions matter. We identify all those whose stature, viewpoint, and connections have the most relevance to your brand.
whose opinionsWe go beyond the scientific literature others rely on. We also gather and analyze large volumes of social media and other text data, where real sentiment may be more timely and easily gauged. matter most. We gather and analyze
dataMany companies cast too broad a net and leave you to process the “catch.” At 81qd, our medical and business technology professionals structure targeted queries. Using computational linguistics, we mine data more accurately, analyze sentiment more clearly, and track changes over time—leading to more useful, actionable insights., measure and track their sentimentWe identify the real opinion leaders, gauge their current thinking, and track shifts in opinion over time. We provide you with an easy-to- use dashboard that gives you access to the data 24/7. over time, and make recommendationsWho are the best people for you to partner with? What is the best way to work with them? Is your work together making a difference? By providing actionable insight, we can answer these questions. based on that information.
We uncover evidence to help differentiate your brand early on using the latest breakthroughs in computer science and computational linguisticsComputational linguistics is the application of computer science techniques to the analysis of language and speech for purposes of interpreting its meaning. Recent breakthroughs allow us to gauge text for relevance and sentiment, and then to track shifts—by individuals and in aggregate—over time..
Our recommendationsData and intelligence are ultimately decision- support tools for strategy development. We go beyond what most other partners offer to provide you with an evidence- based plan of action. and custom reportsOur customizable dashboard provides you 24/7 access and custom searches—so if you need, say, five top opinion leaders in a specific country, you can find them instantly. You’ll also find landscape analysis, message mapping, and viewpoint analysis—on demand. And you can track the effects of your interactions over time. It’s a level of strategic decision support you’ll find nowhere else. apply medical and business acumen to help you optimize your brand’s potentialOur goal is simple—to help your brand live up to its full clinical and commercial potential. In doing so, we aim to help you get more out of every dollar you allocate to clinical development and marketing. Our services are designed to pay for themselves many times over. at every stageFrom product development through market shaping and launch, brand promotions, and label expansion—your interactions with those whose opinions matter most can have a profound effect on your success..
Our medical and scientific expertsMDs, PharmDs, and PhDs—we have more than any other company in our field. understand pharmacology and pathophysiology.
Our marketing professionalsMBAs, analysts, and others with broad experience in the field. Many have worked for pharmaceutical, biotechnology, and medical device companies. know the markets in which your brand competes and the regulatory environment shaping these markets.
Our technology teamComputer scientists, programmers, designers, and other specialists who are skilled in computational linguistics and business technology. is composed of experts in data mining and analytics.